Total Payments
$4,396
2024 Payments
$104.21
Companies
29
Transactions
162
Medicare Patients
4,172
Medicare Billing
$296,480
Payment Breakdown by Category
Food & Beverage$2,955 (67.2%)
Travel$1,435 (32.6%)
Education$6.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,955 | 157 | 67.2% |
| Travel and Lodging | $1,435 | 4 | 32.6% |
| Education | $6.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,897 | 22 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $427.39 | 27 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $394.15 | 24 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $307.87 | 22 | $0 (2023) |
| PFIZER INC. | $202.71 | 14 | $0 (2024) |
| Inari Medical, Inc. | $153.21 | 2 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $148.38 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $106.00 | 6 | $0 (2021) |
| Amgen Inc. | $93.48 | 6 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $76.02 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104.21 | 6 | Novartis Pharmaceuticals Corporation ($61.20) |
| 2023 | $296.74 | 11 | Novartis Pharmaceuticals Corporation ($136.91) |
| 2022 | $270.63 | 10 | Inari Medical, Inc. ($153.21) |
| 2021 | $478.00 | 19 | BOSTON SCIENTIFIC CORPORATION ($148.38) |
| 2020 | $367.21 | 24 | Abbott Laboratories ($62.60) |
| 2019 | $1,868 | 25 | Abbott Laboratories ($1,581) |
| 2018 | $447.59 | 30 | E.R. Squibb & Sons, L.L.C. ($179.73) |
| 2017 | $563.80 | 37 | E.R. Squibb & Sons, L.L.C. ($196.91) |
All Payment Transactions
162 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: Not Applicable | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2023 | Abbott Laboratories | PRESSUREWIRE (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Vascular | ||||||
| 06/28/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/04/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/01/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $102.03 | General |
| Category: Heart Failure | ||||||
| 02/13/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $30.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/01/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/24/2022 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Vascular | ||||||
| 11/08/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: DIABETES | ||||||
| 05/13/2022 | Abbott Laboratories | DRAGONFLY OPSTAR (Device) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Vascular | ||||||
| 05/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $36.75 | General |
| Category: VTE | ||||||
| 03/28/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/22/2022 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $116.46 | General |
| Category: VTE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,072 | 1,303 | $214,156 | $71,172 |
| 2022 | 15 | 937 | 1,096 | $184,859 | $66,705 |
| 2021 | 16 | 1,080 | 1,280 | $215,174 | $80,267 |
| 2020 | 17 | 1,083 | 1,238 | $213,935 | $78,337 |
Total Patients
4,172
Total Services
4,917
Medicare Billing
$296,480
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 182 | $44,226 | $15,766 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 161 | $27,692 | $9,875 | 35.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 155 | 158 | $27,018 | $7,616 | 28.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 65 | 65 | $23,400 | $6,546 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $17,808 | $6,494 | 36.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 65 | 70 | $18,130 | $6,487 | 35.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 45 | $6,696 | $2,739 | 40.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 32 | $7,892 | $2,715 | 34.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 16 | 16 | $9,072 | $2,666 | 29.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $6,157 | $1,962 | 31.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 30 | 30 | $5,100 | $1,541 | 30.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 121 | 151 | $5,587 | $1,534 | 27.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 22 | 64 | $3,776 | $1,259 | 33.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $3,180 | $1,184 | 37.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 25 | 71 | $2,982 | $986.42 | 33.1% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 29 | 29 | $1,508 | $538.38 | 35.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 53 | 56 | $1,120 | $309.80 | 27.7% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 30 | 30 | $960.00 | $295.50 | 30.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 16 | 16 | $800.00 | $291.75 | 36.5% |
| 93246 | Heart rhythm recording of continous external ekg over 8-15 days | Office | 2023 | 27 | 27 | $702.00 | $230.85 | 32.9% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 13 | 14 | $350.00 | $135.10 | 38.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 178 | 250 | $52,919 | $21,863 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 79 | 79 | $24,682 | $9,076 | 36.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 55 | 55 | $26,730 | $7,801 | 29.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 143 | 145 | $24,699 | $7,518 | 30.4% |
About Dr. Bryon Cook, M.D
Dr. Bryon Cook, M.D is a Internal Medicine healthcare provider based in London, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/30/2012. The National Provider Identifier (NPI) number assigned to this provider is 1770841546.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryon Cook, M.D has received a total of $4,396 in payments from pharmaceutical and medical device companies, with $104.21 received in 2024. These payments were reported across 162 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,955).
As a Medicare-enrolled provider, Cook has provided services to 4,172 Medicare beneficiaries, totaling 4,917 services with total Medicare billing of $296,480. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology
- Location London, KY
- Active Since 04/30/2012
- Last Updated 01/22/2026
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1770841546
Products in Payments
- Xience V coronary stent system (Device) $1,634
- ELIQUIS (Drug) $592.09
- ENTRESTO (Drug) $318.48
- LifeVest (Device) $307.87
- FLOWTRIEVER CATHETER, S (Device) $153.21
- GENERAL VASCULAR INTERVENTION (Device) $122.37
- CARDIOMEMS (Device) $102.03
- XARELTO (Drug) $76.02
- LEQVIO (Drug) $75.67
- Zilver PTX (Device) $74.34
- BRILINTA (Drug) $72.79
- Corlanor (Drug) $52.35
- JARDIANCE (Drug) $48.76
- Lumason (Drug) $46.52
- NEXLETOL (Drug) $45.73
- PRALUENT ALIROCUMAB INJECTION (Biological) $38.24
- Dragonfly OCT (Device) $32.51
- DRAGONFLY OPSTAR (Device) $32.47
- UPTRAVI (Drug) $31.49
- VYNDAQEL (Drug) $29.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in London
Mark Adams, M.d, M.D
Internal Medicine — Payments: $195,977
Internal Medicine $195,977
Nancy Morris, M.d, M.D
Internal Medicine — Payments: $20,207
Internal Medicine $20,207
Dr. Michel Bidros, M.d, M.D
Internal Medicine — Payments: $8,854
Internal Medicine $8,854
Kamran Mahmood, Md, MD
Internal Medicine — Payments: $3,304
Internal Medicine $3,304
Syed Mustafa, Md, Mbbs, MD, MBBS
Internal Medicine — Payments: $2,734
Internal Medicine $2,734
Dr. Emily White, M.d, M.D
Internal Medicine — Payments: $1,579
Internal Medicine $1,579